Jian Jin

135PUBLICATIONS
353CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersBiologically active moleculesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (135)

|Oct 06, 2026
PRMT7 restricts CD8+ T cells expansion via the NF-ΚB pathway.

|Sep 29, 2026
Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition.

|Aug 14, 2026
An EZH2-SREBP2 axis promotes cholesterol biosynthesis and represents a noncanonical vulnerability in tumorigenesis.

|May 05, 2026
Discovery of New OTUB1 Covalent Ligands via Structure-Activity Relationship Studies for Targeted Protein Stabilization.

|Apr 23, 2026
Discovery of a Highly Potent and Selective ENL Degrader.

|Mar 26, 2026
A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR.

Yang Yi, Yanqiang Li, Rui Wang

Pageof 23

Frequent Collaborators

26 joint publications

Husnu Ümit Kaniskan

18 joint publications

Xufen Yu

16 joint publications

Wenyi Wei

12 joint publications

Gang Greg Wang